Rfg Bristol Wealth Advisors, LLC Abb Vie Inc. Transaction History
Rfg Bristol Wealth Advisors, LLC
- $298 Billion
- Q1 2025
A detailed history of Rfg Bristol Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rfg Bristol Wealth Advisors, LLC holds 4,655 shares of ABBV stock, worth $845,720. This represents 0.33% of its overall portfolio holdings.
Number of Shares
4,655
Previous 4,481
3.88%
Holding current value
$845,720
Previous $796 Million
22.49%
% of portfolio
0.33%
Previous 0.26%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
4,250Shares Held
1.27BCall Options Held
18MPut Options Held
15.2M-
Vanguard Group Inc Valley Forge, PA174MShares$31.6 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$24.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$14.5 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$9.95 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.48 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $321B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...